Covance Is Now Labcorp Drug Development

We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.

Learn More


End-to-End Support to Advance Gene Therapies for Rare Retinal Diseases

As a promising therapeutic candidate targeting rare inherited retinal diseases was spun out of an academic medical center, Labcorp served an integral role performing analytical testing of their product and ensure the project followed an expedited timeline.

Filed In

Phase IIb
Preclinical & Nonclinical
Rare Disease
Stage (Early, PhI-IIa)
Stage (Late, PhIIb-III)
Therapies - Cell
Therapies - Gene